vs

Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and Federal Realty Investment Trust (FRT). Click either name above to swap in a different company.

Federal Realty Investment Trust is the larger business by last-quarter revenue ($336.0M vs $270.6M, roughly 1.2× Astera Labs, Inc.). Federal Realty Investment Trust runs the higher net margin — 38.6% vs 16.6%, a 22.0% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 8.7%). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 6.5%).

Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.

Federal Realty Investment Trust is a real estate investment trust that invests in shopping centers in the Northeastern United States, the Mid-Atlantic states, California, and South Florida.

ALAB vs FRT — Head-to-Head

Bigger by revenue
FRT
FRT
1.2× larger
FRT
$336.0M
$270.6M
ALAB
Growing faster (revenue YoY)
ALAB
ALAB
+83.1% gap
ALAB
91.8%
8.7%
FRT
Higher net margin
FRT
FRT
22.0% more per $
FRT
38.6%
16.6%
ALAB
Faster 2-yr revenue CAGR
ALAB
ALAB
Annualised
ALAB
103.6%
6.5%
FRT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALAB
ALAB
FRT
FRT
Revenue
$270.6M
$336.0M
Net Profit
$45.0M
$129.7M
Gross Margin
75.6%
Operating Margin
24.7%
53.8%
Net Margin
16.6%
38.6%
Revenue YoY
91.8%
8.7%
Net Profit YoY
82.0%
103.5%
EPS (diluted)
$0.25
$1.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALAB
ALAB
FRT
FRT
Q1 26
$336.0M
Q4 25
$270.6M
$336.0M
Q3 25
$230.6M
$322.3M
Q2 25
$191.9M
$311.5M
Q1 25
$159.4M
$309.2M
Q4 24
$141.1M
$311.4M
Q3 24
$113.1M
$303.6M
Q2 24
$76.8M
$296.1M
Net Profit
ALAB
ALAB
FRT
FRT
Q1 26
$129.7M
Q4 25
$45.0M
$129.7M
Q3 25
$91.1M
$61.6M
Q2 25
$51.2M
$155.9M
Q1 25
$31.8M
$63.8M
Q4 24
$24.7M
$65.5M
Q3 24
$-7.6M
$61.0M
Q2 24
$-7.5M
$112.0M
Gross Margin
ALAB
ALAB
FRT
FRT
Q1 26
Q4 25
75.6%
Q3 25
76.2%
Q2 25
75.8%
Q1 25
74.9%
Q4 24
74.0%
Q3 24
77.7%
Q2 24
77.9%
Operating Margin
ALAB
ALAB
FRT
FRT
Q1 26
53.8%
Q4 25
24.7%
53.8%
Q3 25
24.0%
34.3%
Q2 25
20.7%
65.1%
Q1 25
7.1%
35.0%
Q4 24
0.1%
35.1%
Q3 24
-7.9%
34.9%
Q2 24
-31.7%
53.0%
Net Margin
ALAB
ALAB
FRT
FRT
Q1 26
38.6%
Q4 25
16.6%
38.6%
Q3 25
39.5%
19.1%
Q2 25
26.7%
50.0%
Q1 25
20.0%
20.6%
Q4 24
17.5%
21.0%
Q3 24
-6.7%
20.1%
Q2 24
-9.8%
37.8%
EPS (diluted)
ALAB
ALAB
FRT
FRT
Q1 26
$1.49
Q4 25
$0.25
$1.49
Q3 25
$0.50
$0.69
Q2 25
$0.29
$1.78
Q1 25
$0.18
$0.72
Q4 24
$1.23
$0.74
Q3 24
$-0.05
$0.70
Q2 24
$-0.05
$1.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALAB
ALAB
FRT
FRT
Cash + ST InvestmentsLiquidity on hand
$167.6M
$107.4M
Total DebtLower is stronger
$5.0B
Stockholders' EquityBook value
$1.4B
$3.2B
Total Assets
$1.5B
$9.1B
Debt / EquityLower = less leverage
1.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALAB
ALAB
FRT
FRT
Q1 26
$107.4M
Q4 25
$167.6M
$107.4M
Q3 25
$140.4M
$111.3M
Q2 25
$162.3M
$177.0M
Q1 25
$86.4M
$109.2M
Q4 24
$79.6M
$123.4M
Q3 24
$126.1M
$97.0M
Q2 24
$421.1M
$103.2M
Total Debt
ALAB
ALAB
FRT
FRT
Q1 26
$5.0B
Q4 25
$5.0B
Q3 25
Q2 25
Q1 25
Q4 24
$4.5B
Q3 24
Q2 24
Stockholders' Equity
ALAB
ALAB
FRT
FRT
Q1 26
$3.2B
Q4 25
$1.4B
$3.2B
Q3 25
$1.3B
$3.2B
Q2 25
$1.1B
$3.2B
Q1 25
$1.0B
$3.2B
Q4 24
$964.8M
$3.2B
Q3 24
$889.6M
$3.1B
Q2 24
$845.3M
$3.0B
Total Assets
ALAB
ALAB
FRT
FRT
Q1 26
$9.1B
Q4 25
$1.5B
$9.1B
Q3 25
$1.4B
$8.9B
Q2 25
$1.3B
$8.6B
Q1 25
$1.1B
$8.6B
Q4 24
$1.1B
$8.5B
Q3 24
$983.1M
$8.5B
Q2 24
$915.5M
$8.4B
Debt / Equity
ALAB
ALAB
FRT
FRT
Q1 26
1.53×
Q4 25
1.53×
Q3 25
Q2 25
Q1 25
Q4 24
1.42×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALAB
ALAB
FRT
FRT
Operating Cash FlowLast quarter
$95.3M
Free Cash FlowOCF − Capex
$76.6M
FCF MarginFCF / Revenue
28.3%
Capex IntensityCapex / Revenue
6.9%
Cash ConversionOCF / Net Profit
2.12×
TTM Free Cash FlowTrailing 4 quarters
$281.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALAB
ALAB
FRT
FRT
Q1 26
Q4 25
$95.3M
$622.4M
Q3 25
$78.2M
$147.8M
Q2 25
$135.4M
$150.7M
Q1 25
$10.5M
$179.0M
Q4 24
$39.7M
$574.6M
Q3 24
$63.5M
$144.1M
Q2 24
$29.8M
$169.7M
Free Cash Flow
ALAB
ALAB
FRT
FRT
Q1 26
Q4 25
$76.6M
Q3 25
$65.9M
Q2 25
$133.3M
Q1 25
$6.0M
Q4 24
$24.3M
Q3 24
$46.8M
Q2 24
$28.5M
FCF Margin
ALAB
ALAB
FRT
FRT
Q1 26
Q4 25
28.3%
Q3 25
28.6%
Q2 25
69.5%
Q1 25
3.7%
Q4 24
17.2%
Q3 24
41.4%
Q2 24
37.1%
Capex Intensity
ALAB
ALAB
FRT
FRT
Q1 26
Q4 25
6.9%
Q3 25
5.3%
Q2 25
1.1%
Q1 25
2.8%
Q4 24
10.9%
Q3 24
14.8%
Q2 24
1.7%
Cash Conversion
ALAB
ALAB
FRT
FRT
Q1 26
Q4 25
2.12×
4.80×
Q3 25
0.86×
2.40×
Q2 25
2.64×
0.97×
Q1 25
0.33×
2.81×
Q4 24
1.61×
8.77×
Q3 24
2.36×
Q2 24
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons